June 3, 2019
Rachel Kuperman, MD, CEO, Eysz, Inc.
During Dr. Kuperman's 10 years at UCSF Benioff Children's Hospital, Oakland, she developed the epilepsy program by focusing on excellence in clinical care, and research. She stepped back to focus on developing Eysz. Eysz comes out of her clinical work to help parents, caregivers and physicians quantitate the burdens of epilepsy: seizures, side effects and cognitive effects. The goal of Eysz is to improve the lives of people with epilepsy by leaving no seizure, side effect or complication undetected.
May 20, 2019
Holly Rockweiler, Co-Founder & CEO, Madorra
Holly Rockweiler is co-founder and CEO of Madorra, a women’s health company dedicated to changing the treatment paradigm for vaginal dryness.
Rockweiler co-founded Madorra three years ago as a spin-out of the Stanford Biodesign Fellowship. Prior to Biodesign, she worked as a senior research scientist in the Cardiac Rhythm Management division of Boston Scientific. There, she co-developed a new sensing algorithm for cardiac resynchronization therapy that enables more efficient care for patients living with heart failure. Her work has led to 15 pending and issued patents. Rockweiler holds a Master of Science and a Bachelor of Science in biomedical engineering from Washington University in St. Louis.
May 3, 2019
Matthew Likens, President and CEO, GT Medical Technologies
Matt Likens is currently president and CEO of GT Medical Technologies, Inc., inventors of Gammatile(TM) Therapy, with a corporate purpose of "Improving the Lives of Patients with Brain Tumors". Previously, he held the same position at Ulthera, Inc., which grew from start-up to over $100M in revenue before being sold to Merz Pharma in July, 2014, for $600M. Prior to that, Matt began his career at J&J before spending the bulk of his career at Baxter Healthcare International, where he held ascending levels of responsibility, culminating in positions as President Biotech North America and President of Renal Dialysis in the U.S. He is a board member of privately-held Luma Therapeutics where they are commercializing their novel and effective approach to use UV light and coal tar patches to treat psoriasis, and publicly-traded CHF Solutions, which sells the AquaDex System to effectively reduce fluid overload in patients. He is a past winner of the Ernst &Young Mountain and Desert Region Entrepreneur of the Year award, is an active member of the Greater Phoenix Economic Council Healthcare Advisory Committee, and also is a member of the City of Mesa Economic Development Council. Matt remains active with his alma mater, Kent State University as a member of their College of Business Administration Advisory Board.
April 22, 2019
Dorna Hakimi, PhD, Founder & CEO, BioInspire Technologies
Dorna Hakimi, PhD, is CEO of BioInspire Technologies, a Palo Alto startup whose core technology is a bioresorbable, biocompatible medical film that can deliver therapies to specific locations.
BioInspire has developed a flexible, therapeutic film made of human plasma fibrinogen, a naturally occurring protein. The film can be easily placed on surface tissue or delivered to a remote tissue using non-invasive delivery tools.
Originally from Iran, Dorna completed a PhD at the University of British Columbia. While a graduate student, she began working at MIV Therapeutics, where she continued after earning her doctorate. She held positions at Medlogics Device Corporation and Osseon Therapeutics before founding BioInspire in 2009.
April 4, 2019
Caroline Corner, PhD, Managing Partner, Westwicke Partners
Caroline Corner, Ph.D., joined Westwicke Partners in 2016 as a Managing Director leading our San Francisco effort in Medical Technology. Caroline’s focus is working with both public and private companies in the medical device and diagnostics areas. Her expertise and extensive C-level industry relationships stem from more than 12 years working in sell-side equity research, various roles within device and healthcare companies, as well as her academic training in biochemistry, engineering and nanobiotechnology.
March 22, 2019
Niquette Hunt, CEO, Candesant Biomedical
Niquette Hunt, CEO, has over twenty-five years’ experience in developing, launching and commercializing 20+ products across multiple verticals in the consumer medicine market. Every business she managed increased sales, profits and/or market share. Before founding Candesant, Ms. Hunt charted the commercial strategy at Revance Therapeutics and helped raise over $250 million in the 2014 IPO and follow-on financing.
March 11, 2019
Steve Axelrod, PhD, President & CEO, G-Tech Medical
Steve received his Ph.D. from Yale in Elementary Particle Physics and did his post-doc in the same field at Stanford. He worked at Measurex-Honeywell for 15 years where he was Director of Measurement System and Hardware Engineering. In 2003 he entered the medical device field, and helped develop and commercialize the Xoft Axxent microTube and radiation therapy delivery system. Steve has led teams delivering numerous best in class systems and devices in both medical devices and industrial automation. Some examples are nuclear basis weight, X-ray and infrared absorption sensors, Large scanning frames, fast high channel count data acquisition systems, skin and vaginal applicators for radiation therapy, high precision measurement systems for characterizing and testing system and device performance. Steve has been CEO of G-Tech since November 2011. This project combines his experience leading high performance R&D teams, his passion for medical devices and his expertise in creating sophisticated measurement systems.
February 25, 2019
Jonathan Coe, Co-Founder, President & CEO, Prescient Surgical
With more than a decade of experience in the medical device industry, Jon is both an inventor and a leader. Before co-founding Prescient Surgical as a Stanford Biodesign Innovation Fellow, Jon held a range of roles in engineering, marketing, and leadership in the surgical instrument divisions of Johnson & Johnson and Covidien. He is an inventor on 25 issued patents and successfully launched four major products in bariatric, general, and natural orifice surgery, and surgical oncology. He also started two interventional cardiology companies, Metavention and Gradient Therapeutics, and led the IP, technical, and pre-clinical efforts at Metavention through a successful Series B investment. Jon holds SB and MS degrees in Mechanical Engineering from MIT and Georgia Tech, respectively.
February 14, 2019
Shubhra Jain, MD, Senior Associate, Cota Capital
Dr. Shubhra Jain joined Cota in 2018 as a Senior Associate where she is responsible for sourcing, executing and analyzing healthcare investments. Prior to Cota, Shubhra was Associate Director of Commercial Strategy and Corporate Development at Natera where she focused on Biopharma Partnerships, the diligence of potential acquisitions, market research and competitive positioning. Prior to Natera, she led Product management for Acute care suite of products at Pieces Technologies where she led product development and launch of SaaS risk surveillance and prediction solutions for clinical outcomes and published peer-reviewed research on the subject. Prior to Pieces, Dr. Jain served as a consultant and an advisor to several health tech startups and Fortune 500 companies.
Dr. Jain is a Primary Care Physician from India, has her Masters in Engineering from Stanford with a major in Biodesign and her MBA from the Wharton School of Business.
February 11, 2019
Ryan Pierce, Co-Founder and CEO, Nine, & Lecturer in Bioengineering, Stanford
This is a recording of a live event. Download the presentation deck
Ryan Pierce is Co-Founder and CEO of Nine, Entrepreneur-in-Residence at Rock Health, and Lecturer in Bioengineering at Stanford, where he teaches BIOE 70Q: Medical Device Innovation. He has served as VP of Design and Innovation at Ventus Medical, VP of Business Development at Loma Vista Medical, a healthcare investor at De Novo Ventures, and a product designer at Concentric Medical and The Foundry/Zephyr Medical. An inventor on over two dozen issued U.S. patents, he has designed FDA-cleared devices to treat sleep apnea and stroke. Ryan holds mechanical engineering degrees from MIT and Stanford, and an MBA from Harvard Business School.